Eye fluid analysis may unlock clues for untreated form of macular degeneration
NCT ID NCT03418220
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This completed study examined inflammation markers in the fluid from the eyes of 82 people with different stages of age-related macular degeneration (AMD) and a control group without AMD. Researchers collected samples during cataract surgery and tested for 27 inflammation-related molecules. The goal was to identify specific patterns that could help understand the dry (atrophic) form of AMD, for which no treatment currently exists, and potentially guide future therapies.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If specific inflammation markers are found in atrophic AMD, this could point toward new targeted treatments for a form of the disease that currently has no therapy.
- What could go wrong
- This is an observational study, not a treatment trial. It is small (82 participants) and only looks at markers in eye fluid, so any link to future therapies is uncertain and far off.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ATROPHIC AGE-RELATED MACULAR DEGENERATION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Hôpital de la Croix-Rousse
Lyon, 69004, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new eye drug cut injection frequency for AMD patients?
- Should gene therapy be used for AMD? new study asks patients
- Eye imaging showdown: which device measures macular damage best?
- Bionic eye implant aims to bring back sight in advanced macular degeneration
- Scientists probe eye fluid to uncover why some macular degeneration patients Don't get better
- Can a stronger eylea dose dry up wet AMD faster?